Infinimmune Raises $75M To Advance Human Antibody Pipeline
Infinimmune Raises $75M For Clinical Development Infinimmune has raised $75 million in Series A funding to advance its antibody therapeutics pipeline. The financing was co-led by Regeneron Ventures and Playground The post Infinimmune Raises $75M To Advance Human Antibody Pipeline appeared first on Ventureburn .
We haven't written up this one. Ventureburn has the full story — the link below goes straight to it.